These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 23767159)

  • 1. Risk factors for osteonecrosis of the jaws: a case-control study from the CONDOR Dental PBRN.
    Barasch A; Cunha-Cruz J; Curro FA; Hujoel P; Sung AH; Vena D; Voinea-Griffin AE; Beadnell S; Craig RG; DeRouen T; Desaranayake A; Gilbert A; Gilbert GH; Goldberg K; Hauley R; Hashimoto M; Holmes J; Latzke B; Leroux B; Lindblad A; Richman J; Safford M; Ship J; Thompson VP; Williams OD; ; Wanrong Y
    Tex Dent J; 2013 Apr; 130(4):299-307. PubMed ID: 23767159
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk factors for osteonecrosis of the jaws: a case-control study from the CONDOR dental PBRN.
    Barasch A; Cunha-Cruz J; Curro FA; Hujoel P; Sung AH; Vena D; Voinea-Griffin AE; ; Beadnell S; Craig RG; DeRouen T; Desaranayake A; Gilbert A; Gilbert GH; Goldberg K; Hauley R; Hashimoto M; Holmes J; Latzke B; Leroux B; Lindblad A; Richman J; Safford M; Ship J; Thompson VP; Williams OD; Yin W
    J Dent Res; 2011 Apr; 90(4):439-44. PubMed ID: 21317246
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dental risk factors for osteonecrosis of the jaws: a CONDOR case-control study.
    Barasch A; Cunha-Cruz J; Curro F; DeRouen T; Gilbert GH; Hujoel P; Safford MM; Vena DA; Voinea-Griffin AE; Wu H;
    Clin Oral Investig; 2013 Nov; 17(8):1839-45. PubMed ID: 23212125
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risks for jaw osteonecrosis drastically increases after 2 years of bisphosphonate therapy.
    Akintoye SO; Hersh EV
    J Evid Based Dent Pract; 2012 Sep; 12(3 Suppl):251-3. PubMed ID: 23253854
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Canadian consensus practice guidelines for bisphosphonate associated osteonecrosis of the jaw.
    Khan AA; Sándor GK; Dore E; Morrison AD; Alsahli M; Amin F; Peters E; Hanley DA; Chaudry SR; Dempster DW; Glorieux FH; Neville AJ; Talwar RM; Clokie CM; Al Mardini M; Paul T; Khosla S; Josse RG; Sutherland S; Lam DK; Carmichael RP; Blanas N; Kendler D; Petak S; St-Marie LG; Brown J; Evans AW; Rios L; Compston JE;
    J Rheumatol; 2008 Jul; 35(7):1391-7. PubMed ID: 18528958
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nature and frequency of bisphosphonate-associated osteonecrosis of the jaws in Australia.
    Mavrokokki T; Cheng A; Stein B; Goss A
    J Oral Maxillofac Surg; 2007 Mar; 65(3):415-23. PubMed ID: 17307586
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Longitudinal cohort study of risk factors in cancer patients of bisphosphonate-related osteonecrosis of the jaw.
    Vahtsevanos K; Kyrgidis A; Verrou E; Katodritou E; Triaridis S; Andreadis CG; Boukovinas I; Koloutsos GE; Teleioudis Z; Kitikidou K; Paraskevopoulos P; Zervas K; Antoniades K
    J Clin Oncol; 2009 Nov; 27(32):5356-62. PubMed ID: 19805682
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical investigation of C-terminal cross-linking telopeptide test in prevention and management of bisphosphonate-associated osteonecrosis of the jaws.
    Kunchur R; Need A; Hughes T; Goss A
    J Oral Maxillofac Surg; 2009 Jun; 67(6):1167-73. PubMed ID: 19446200
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Osteonecrosis of the jaw onset times are based on the route of bisphosphonate therapy.
    Fleisher KE; Jolly A; Venkata UD; Norman RG; Saxena D; Glickman RS
    J Oral Maxillofac Surg; 2013 Mar; 71(3):513-9. PubMed ID: 22999296
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bisphosphonate-related osteonecrosis of the jaws: a case-control study of risk factors in breast cancer patients.
    Kyrgidis A; Vahtsevanos K; Koloutsos G; Andreadis C; Boukovinas I; Teleioudis Z; Patrikidou A; Triaridis S
    J Clin Oncol; 2008 Oct; 26(28):4634-8. PubMed ID: 18574158
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A review of the literature on osteonecrosis of the jaw in patients with osteoporosis treated with oral bisphosphonates: prevalence, risk factors, and clinical characteristics.
    Pazianas M; Miller P; Blumentals WA; Bernal M; Kothawala P
    Clin Ther; 2007 Aug; 29(8):1548-58. PubMed ID: 17919538
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The national-scale cohort study on bisphosphonate-related osteonecrosis of the jaw in Taiwan.
    Yuh DY; Chang TH; Huang RY; Chien WC; Lin FG; Fu E
    J Dent; 2014 Oct; 42(10):1343-52. PubMed ID: 24907558
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bisphosphonate-related osteonecrosis of the jaws - characteristics, risk factors, clinical features, localization and impact on oncological treatment.
    Otto S; Schreyer C; Hafner S; Mast G; Ehrenfeld M; Stürzenbaum S; Pautke C
    J Craniomaxillofac Surg; 2012 Jun; 40(4):303-9. PubMed ID: 21676622
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ONJ in two dental practice-based research network regions.
    Fellows JL; Rindal DB; Barasch A; Gullion CM; Rush W; Pihlstrom DJ; Richman J;
    Tex Dent J; 2013 Apr; 130(4):311-8. PubMed ID: 23767160
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Large National Cohort Study of the Association between Bisphosphonates and Osteonecrosis of the Jaw in Patients with Osteoporosis: A Nested Case-control Study.
    Kwon JW; Park EJ; Jung SY; Sohn HS; Ryu H; Suh HS
    J Dent Res; 2015 Sep; 94(9 Suppl):212S-9S. PubMed ID: 26001708
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bisphosphonate-induced osteonecrosis of the jaws: prospective study of 80 patients with multiple myeloma and other malignancies.
    Boonyapakorn T; Schirmer I; Reichart PA; Sturm I; Massenkeil G
    Oral Oncol; 2008 Sep; 44(9):857-69. PubMed ID: 18282788
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dental implants in patients treated with antiresorptive medication - a systematic literature review.
    Walter C; Al-Nawas B; Wolff T; Schiegnitz E; Grötz KA
    Int J Implant Dent; 2016 Dec; 2(1):9. PubMed ID: 27747701
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence and risk factors of bisphosphonate-associated osteonecrosis of the jaw in prostate cancer patients with advanced disease treated with zoledronate.
    Walter C; Al-Nawas B; Grötz KA; Thomas C; Thüroff JW; Zinser V; Gamm H; Beck J; Wagner W
    Eur Urol; 2008 Nov; 54(5):1066-72. PubMed ID: 18602738
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incidence of bisphosphonate-associated osteonecrosis of the jaws in breast cancer patients.
    Walter C; Al-Nawas B; du Bois A; Buch L; Harter P; Grötz KA
    Cancer; 2009 Apr; 115(8):1631-7. PubMed ID: 19156913
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bisphosphonate-associated osteonecrosis of the jaw in Ontario: a survey of oral and maxillofacial surgeons.
    Khan AA; Rios LP; Sándor GK; Khan N; Peters E; Rahman MO; Clokie CM; Dore E; Dubois S
    J Rheumatol; 2011 Jul; 38(7):1396-402. PubMed ID: 21498483
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.